ArticleJournal of applied clinical medical physics2025
Optimizing lung SBRT delivery: A hybrid approach combining dynamic conformal arc (DCA) and volumetric modulated arc therapy (VMAT) techniques.
Article in Journal of applied clinical medical physics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeThis study introduces and evaluates a hybrid dynamic conformal arc-volumetric modulated arc therapy (hDCA-VMAT) technique for lung stereotactic body radiotherapy (SBRT). The goal is to combine the planning efficiency of VMAT with the delivery robustness of dynamic conformal arc (DCA) techniques, particularly for low-density lung targets where motion and dose calculation uncertainties pose challenges.
methodsTwenty-four previously treated lung SBRT cases were retrospectively replanned using hDCA-VMAT, conventional VMAT, and aperture controlled VMAT (VMAT_AC). hDCA-VMAT plans were initiated with a manually created DCA plan, followed by limited inverse optimization with constrained aperture modulation. Plans were created in Eclipse v16.1 and calculated using the AcurosXB algorithm. Dosimetric plan quality, beam complexity, and delivery efficiency were assessed. Complexity was quantified using aperture-based metrics (e.g., average leaf pair opening, beam area, modulation index). Pretreatment delivery accuracy was evaluated via EPID-based gamma analysis at 3%/1, 2%/1, and 1%/1 mm Gamma criteria.
resultsAll techniques produced clinically acceptable plans. Target coverage and conformity indices were comparable, but hDCA-VMAT plans demonstrated reduced mid-dose spread and significantly lower modulation. hDCA-VMAT achieved the lowest modulation factor (2.1 ± 0.52) and shortest beam on time (1.74 ± 0.46 min), a 27%-30% reduction compared to VMAT and VMAT_AC. Beam complexity metrics confirmed larger, more circular apertures for hDCA-VMAT. Gamma pass rates were significantly higher for hDCA-VMAT across all criteria, particularly under stringent 1%/1 mm criteria.
conclusionThe hDCA-VMAT technique offers a practical, streamlined approach for lung SBRT planning that reduces modulation while maintaining high plan quality. By initiating with a DCA plan and applying limited optimization only when necessary, hDCA-VMAT minimizes planning complexity and improves delivery efficiency. These benefits are especially relevant for treating low-density lung tumors, where robustness to motion and delivery accuracy are critical.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.